Sabag Mark
SEC CIK 1721442 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | See "Remarks" | 80.8K | — | $23.48M | 21 | 2022-02-09 | 2026-05-01 |
Most active insiders at TEVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Francis Richard D | Pres, CEO | — | $31.26M |
| 2 | MIGNONE ROBERTO | Dir | — | $22.82M |
| 3 | Kalif Eliyahu Sharon | EVP, CFO | — | $20.72M |
| 4 | Sabag Mark | See "Remarks" | — | $13.15M |
| 5 | Daniell Richard | EVP, European Commercial | — | $12.08M |
| 6 | Hughes Eric A | See "Remarks" | — | $4.17M |
| 7 | Fox Christine | EVP, U.S. Commercial | — | $2.75M |
| 8 | Lippman Evan | EVP, Business Development | — | $2.16M |
| 9 | Weiss Amir | CAO | — | $1.41M |
| 10 | Shields Matthew | EVP, Gbl Ops | — | $1.40M |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 16:02 | 2026-05-01 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | See "Remarks" | S - Sale | $34.99 | -144.2K | 80.8K | -64% | -$5.05M | |
| 2026-03-19 | 2026-03-17 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | See "Remarks" | S - Sale | $30.14 | -62.1K | 224.9K | -22% | -$1.87M | |
| D | 2026-03-09 | 2026-03-05 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | See "Remarks" | M - OptEx | — | +15.7K | 287.0K | +6% | — |
| DM | 2026-03-06 | 2026-03-04 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | See "Remarks" | M - OptEx | — | +52.1K | 252.7K | +26% | — |
| DM | 2026-03-05 | 2026-03-03 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | See "Remarks" | M - OptEx | — | +166.4K | 77.7K | New | — |
| DM | 2025-12-11 | 2025-12-09 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | See "Remarks" | S - Sale+OE | $28.73 | -216.9K | 151.0K | -59% | -$6.23M |
| D | 2025-12-11 | 2025-12-09 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | See "Remarks" | M - OptEx | $18.61 | +118.7K | 269.7K | +79% | +$2.21M |
| 2025-05-12 | 2025-05-08 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | See "Remarks" | S - Sale | $18.04 | -337.9K | 151.0K | -69% | -$6.10M | |
| D | 2025-03-07 | 2025-03-05 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | See "Remarks" | M - OptEx | — | +23.8K | 488.9K | +5% | — |
| DM | 2025-03-06 | 2025-03-04 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | See "Remarks" | M - OptEx | — | +235.3K | 282.0K | +504% | — |
| D | 2025-03-05 | 2025-03-03 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | See "Remarks" | M - OptEx | — | +24.9K | 229.9K | +12% | — |
| 2025-02-14 | 2025-02-12 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | See "Remarks" | S - Sale | $16.25 | -177.6K | 205.0K | -46% | -$2.89M | |
| DM | 2024-03-07 | 2024-03-05 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | EVP, International Markets | M - OptEx | — | +81.9K | 482.6K | +20% | — |
| D | 2024-03-07 | 2024-03-05 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | EVP, International Markets | S - Sale+OE | $13.52 | -100.0K | 382.6K | -21% | -$1.35M |
| DM | 2024-03-05 | 2024-03-03+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | EVP, International Markets | M - OptEx | — | +58.4K | 367.2K | +19% | — |
| D | 2024-03-01 | 2024-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | EVP, International Markets | M - OptEx | — | +20.6K | 342.3K | +6% | — |
| DM | 2023-03-07 | 2023-03-04+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | EVP, International Markets | M - OptEx | — | +73.2K | 282.0K | +35% | — |
| DM | 2023-03-02 | 2023-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | EVP, International Markets | M - OptEx | — | +70.8K | 198.2K | +56% | — |
| DM | 2022-03-08 | 2022-03-04+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | EVP, International Markets | M - OptEx | — | +83.0K | 110.5K | +302% | — |
| D | 2022-03-02 | 2022-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | EVP, International Markets | M - OptEx | — | +20.6K | 94.6K | +28% | — |
| D | 2022-02-10 | 2022-02-09 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | EVP, International Markets | M - OptEx | — | +15.5K | 74.0K | +27% | — |
Purchase Sale Sale after option exercise All abbreviations